TrialClinical and translational science2020

Comparing Model Performance in Characterizing the PK/PD of the Anti-Myostatin Antibody Domagrozumab.

Abhinav Tiwari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.